Opsens (TSX:OPS) ROCE % : -3.69% (As of Aug. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Opsens ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Opsens's annualized ROCE % for the quarter that ended in Aug. 2023 was -3.69%.

Opsens ROCE % Historical Data

The historical data trend for Opsens's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens ROCE % Chart

Opsens Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

ROCE %

Get a 7-Day Free Trial

-7.06

-7.03

-0.99

-23.62

-27.82

Opsens Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
ROCE %	Get a 7-Day Free Trial															-36.00	-38.57	-29.01	-35.39	-3.69

Opsens ROCE % Calculation

Opsens's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	-11.403	/	( ( (48.511 - 8.601)	+	(50.832 - 8.778) )	/ 2 )
	=	-11.403	/	( (39.91	+	42.054)	/ 2 )
	=	-11.403	/	40.982
	=	-27.82 %

Opsens's ROCE % of for the quarter that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Aug. 2023 )		(Q: May. 2023 )		(Q: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Aug. 2023 )		(Q: May. 2023 )		(Q: Aug. 2023 )
	=	-1.592	/	( ( (54.169 - 9.924)	+	(50.832 - 8.778) )	/ 2 )
	=	-1.592	/	( ( 44.245	+	42.054 )	/ 2 )
	=	-1.592	/	43.1495
	=	-3.69 %

(1) Note: The EBIT data used here is four times the quarterly (Aug. 2023) EBIT data.

Opsens (TSX:OPS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Opsens ROCE % Related Terms

Thank you for viewing the detailed overview of Opsens's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines